Secondary Logo

Journal Logo


JAIDS Journal of Acquired Immune Deficiency Syndromes: April 2011 - Volume 56 - Issue - p 34-40
doi: 10.1097/01.qai.0000397293.95303.3a
Abstract Index

To navigate to an abstract, simply click on the number or name of the abstract.

102 HIV-DNA and HIV Therapy d'Ettore, Gabriella - Univserity of Rome

105 HIV and Viral Associated Malignancy Blattner, William - Institute of Human Virology

106 Cancer Research in Africa Adebamowo, Clement - Institute of Human Virology

107 Cancer and HIV in Sub-Saharan Africa: Not Exactly as in the North Sasco, Annie – Victor Ségalen Bordeaux 2 University

108 HIV-1C of Southern Africa: Why is the Virus More Fit? Essex, Max - Harvard School of Public Health

109 Epidemiology of AIDS-Related Malignancies: Current Knowledge and Opportunities for Etiological Studies in the Setting of HIV Treatment Programs Mbulaiteye, Sam - NCI

110 Nef-Trafficking Intercellular Highways for HIV Evasion of Antibody Production Cerutti, Andrea - Mount Sinai School of Medicine

111 Generation of Cells Within Human Nurse Macrophages and Consequences Following HIV Infection Gartner, Suzanne - Institute of Human Virology

112 Multifaceted Infection and Replication of HIV-1 in Human Macrophages Poli, Guido - San Raffaele Scientific Institute

113 Murder on the HIV Express: Insights into How CD4 T Cells are Killed in Lymphoid Tissues Greene, Warner C. - Gladstone Institute

114 HIV Interactions With Other Viruses in Human Tissues as Determinants of HIV Infection Margolis, Leonid - National Institutes of Child Health and Human Development

115 HIV-1 Rev and Regulation of Rev Nucleo-Cytoplasmic Shuttling Hall, William - Centre for Research in Infectious Diseases, University College Dublin

118 Inhibiting CCR5 in vitro and in vivo Moore, John P - Cornell

119 Viral Attack and Cellular Defense: The Role of Cellular Restrictions in the Biology of Primate Lentiviruses Stevenson, Mario - University of Massachusetts

120 HIV Persistence Challenging Therapeutic Success Lafeuillade, Alain - General Hospital, Toulon, France

121 Functional Implication of γδ t Cell Depletion in HIV Disease Pauza, C. David - Institute of Human Virology

122 Interplay Between HIV Replication and MicroRNAs Benkirane, Monsef - Institute of Human Genetics CNRS

123 Molecular Mechanisms of HIV Latency Verdin, Eric - Gladstone Institute

124 CCR6 Ligands Inhibit HIV in Highly Susceptible CD4+CCR6+ T cells by Inducing APOBEC3G Expression Garzino-Demo, Alfredo - Institute of Human Virology

125 Naturally c-Terminally Truncated STAT5 (STAT5Δ): A Negative Controller of HIV-1 Transcription and Expression Della Chiara, Giulia - San Raffaele Scientific Institute

126 PML Nuclear Bodies Determine the Repressive Environment and Restrict Viral Gene Expression in Primary Human Lymphocytes Lusic, Marina - San Raffaele Scientific Institute

127 Characterization of Tripartite-Motif (TRIM) 22-Mediated Inhibition of HIV-1 Transcription Vicenzi, E. - San Raffaele Scientific Institute

128 Suppression of CCR5 Density as a Novel Way to Enhance the Anti-HIV Activity of Fusion Inhibitors and CCR5 Antagonists Latinovic, Olga - Institute of Human Virology

129 HIV and Immune System Deregulation Rizos, Apostolos - University of Crete

131 The Role of Chitinase 3-Like-1 in the Pathological Deposition of Collagen in Lympatic Tissue During HIV-1 Infection Smith, A.J. - University of Minnesota

132 Identification of New Patterns of Splice Site Usage by Transcripts of HIV-1 Primary Isolated of Diverse Subtypes Thomson, Michael - Institute de Salud Carlos III

133 Aptamer-siRNA Chimera Therapy Suppresses HIV-1 Viral Loads and Protects from CD4 T-Cell Loss in Humanized (RAG-hu) Mice Akkina, Ramesh - Colorado State University

134 Population Level Variations in the Baseline Value for Vδ2 T Cells and Implications for the Study of Infections Diseases Cairo, Cristiana - Institute of Human Virology

135 Reconstitution of Conformational B-Cell Epitopes Using Combinatorial Conformer Libraries Freund, Natalia - Tel Aviv University

136 HTLV-2 Tax-2 Transactivator Increases the Expression and the Function of its Inhibitor CIITA, the Master Regulator of HLA-II Gene Transcription Orlandi, Chiara - University of Insubria

138 Building on the Results of the RV144 Prime Boost HIV Vaccine Efficacy Study Michael, Nelson - U.S. Military HIV Research Program

139 A Novel Nanoparticle Approach to Induce Colorectal and Vaginal Mucosal Immunity Berzofsky, Jay - National Cancer Institute

140 Induction of Efficacious Immune Responses Using Heterologous Prime Boost Regimens of Recombinant DNA and MVA HIV Vaccines and GM-CSF as the Adjuvant Newman, Mark - GeoVax

141 Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 Stamatatos, Leonidas - Seattle BioMed

142 Steps Toward Epitope-Based Vaccines Gershoni, Jonathan - Tel Aviv University

143 HIV Transmission: The Role of Neutralizing Antibodies Overbaugh, Julie - Fred Hutchinson Cancer Research Center

144 Protection Against Heterologous SHIV Challenge Afforded by Immunization of Rhesus Macaques With a Subunit Immunogen That Mimics a Transition State HIV Envelope Structure DeVico, Anthony - Institute of Human Virology

146 Strong and Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Prime MVA Boost Vaccine Regimen Among Health Tanzanian Volunteers Biberfeld, Gunnel - Karolinska Institutet

147 Rational Design of Envelope Surface Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 Nabel, Gary - Vaccine Research Center, NIH

148 Moving Forward from RV144: An Industrial Perspective Tartaglia, Jim - Sanofi Pasteur, Ltd. 

149 Novel Vectors and Antigens for a Next Generation HIV-1 Vaccine Barouch, Dan - Beth Israel Deaconess Medical Center

150 Retooling the Macaque Model as a Necessary Step to Evaluate the Relative Efficacy of Vaccines for HIV Franchini, Genoveffa - National Cancer Institute

151 Role of Poxvirus Vectors in the Development of an HIV Vaccine Pantaleo, Giuseppi - University of Lausanne

152 TLR8 Triggering Induces HIV from Latently Infected Cells of Myeloid Monocytic Origin and Indirectly from Latently Infected CD4+ T Cells Via the MAPK Pathway and TNF-α Respectively Speck, Roberto F - University Hospital of Zurich

153 Modeling HIV-1 Latency in vitro Romerio, Fabio - Institute of Human Virology

154 Anti-HIV-1 RANTES Derivatives Acting as CCR5 Antagonists Present Full Additivity or Synergy in Combination With Different Entry/Fusion Inhibitors Secchi, Massimiliano - San Raffaele Scientific Institute

155 HIV-1 Infection and Replication of Cervico-Vaginal Histocultures Saba, Elisa - San Raffaele Scientific Institute

156 A Live Microbicide Shows Efficacy in a Repeated Low Dose Challenge Model Lagenaur, Laurel - National Cancer Institute

157 Fusion Complexes and CD-4 Independent Eng for the Induction of Broad Spectrum Neutralizing Antibodies Against HIV-1 Zipeto, Donato - University of Verona

157a HLA-C Associates with Eng and Increases HIV-1 Infectivity Zipeto, Donato - University of Verona

158 HIV-1 Matrix Protein p17: A Candidate Antigen for Therapeutic Vaccines Against AIDS Caruso, Arnaldo - University of Brescia

159 Immune Signatures and Systems Biology of Vaccines Buonaguro, Luigi - National Cancer Institute, Fond Pascale

160 Recombinant Vector-Based Vaccines for Cancer Therapy Schlom, Jeffrey - National Cancer Institute, Bethesda

161 Dentritic Cell Vaccination in Acute Myeloid Leukemia Berneman, Zwi - University of Antwerp and Antwerp University Hospital

162 Active Anti-IFN α Immunotherapy Applied to Chronic Viral and Autoimmune Diseases Zagury, Daniel - Neovacs

162a Update on Kinoids as an Active Immunotherapy to Combat Pathogenic Cytokines in Viral, Cancer and Autoimmune Diseases: Safety, Immunogenicity Zagury, Daniel - Neovacs 

163 New Immune Strategies to Reduce CCR5 Expression and Block HIV Infection Lopalco, Lucia - San Raffaele Scientific Institute

164 Using Epitopes Recognized by Monoclonal Antibodies as Vaccine Templates Zolla-Pazner, Susan - NYU School of Medicine

165 Reconsidering a Live-Attenuated HIV Vaccine? Berkhout, Ben - University of Amsterdam

166 Fc-Mediated Anti-HIV Effector Function Mediated by New Monoclonal Antibodies That Recognize Epitopes Selectively Exposed During Viral Entry Lewis, George - Institute of Human Virology

167 Magnitude and Breadth of the Neutralizing Antibody Response in RV144 Montefiori, David - Duke University Medical Center

169 SIV Infection of Natural Hosts Silvestri, Guido - Emory University

172 Monitoring HIV Drug Resistance as a Guide to Understanding Viral Pathogenesis Wainberg, Mark - McGill University

174 Salvage Therapy in HIV-1 Infected Patients Castagna, Antonella - San Raffaele Scientific Institute

175 HIV-1 Evolution in Primary Infection in Affected by Stochastic Followed by Selective Processes Mullins, James - University of Washington

176 Exploring the Potential of CCR5 and CXCR4 Modified CD4 T Cells to Target the HIV-1 Reservoir June, Carl - University of Pennsylvania

177 Peptide Linkers Between Natural Antibodies and HIV Target Vahlne, Anders - Karolinska Institute

178 Targeting Cell Cycle to Enhance the Potency of Antiretroviral Therapeutic Agents Redfield, Robert - Institute of Human Virology

180 Adult T-Cell Leukemia/Lymphoma in Japan: Reminisciences and Perspectives Takatsuki, Kiyoshi- Kumamoto University School of Medicine

181 HTLV-1 Research After Three Decades: Insights into Cellular Transformation Mechanisms for ATL (Adult T-Cell Leukemia) Jeang, K.T. - National Institutes of Health

182 Risk Indicators for Disease Progression in Asymptomatic HTLV-1 Carriers: A Nationwide Prospective Study in Japan and Expression Profile Analysis Based on the Material Bank Watanabe, Toshiki - The University of Tokyo

183 HIV Exposes Major “Trafficking” in HERV-K HML-2 Viruses Which are Critical to the Pathogenesis of HIV Infection and Lymphoma Kaplan, Mark - University of Michigan

184 Beneficial and Detrimental Effects of Human Endogenous Retroviruses (HERVs) Kurth, Reinhard - Robert Koch Institute

185 Do Modern Endogenous Retroviruses Still Replicate? Markovitz, David - University of Michigan

186 Awakening Dormant Tumor Cells by Inflammation Klein, Georg - Karolinska Institutet

187 KSHV, Angionesis and Kaposi Sarcoma Di Luca, Dario - Universiry of Ferrara

188 VEGF-Notch-EphrinB2 Pathways in AIDS-Related Kaposi Sarcoma Gill, Parkash - University of Southern California

189 HIV Tropism and Decreased Risk of Breast Cancer Goedert, James J. - Infections and Immunoepidemiology Branch, National Cancer Institute, NIH

190 Novel Classes of p53 Activators for Cancer Therapy Lu, Wuyuan - Institute of Human Virology

191 Sensitizing Hemopoietic Malignant Cells to Glucocorticoid Induced Apoptosis by PK Inhibitors

Yefenof, Eitan - Lautenberg Center for General and Tumor Immunology, The Hebrew University - Hadassah Medical School

192 Cross-Talk with the Microenvironment: The Case of Melanoma Brain Metastasis Witz, Isaac - Tel Aviv University

193 The Possible Evolutionary Role of Tumors in the Origin of New Cell Types Kozlov, A.P. - The Biomedical Center

194 HPV-Related Cancers in HIV-Infected Subjects Buonaguro, Franco - National Cancer Institute, Fond Pascale

195 Hepatits C Virus-Specific Immune Response Among Egyptian Healthcare Workers at High Risk of Infection Without Viremia or Seroconversion Abdelwahab, Sayed - Minia University

196 Newly Identified Circulating Recombinant Form Coming in Nigeria Carr, J.K. - Institute of Human Virology

197 Population Level Drug Resistance in HIV Type 1 Protease and Reverse Transcriptase in Cameroon: 1995-2010 Review Torimiro, Judith - Chantal Biya International Reference Centre

198 Identification of a Human Natural Regulatory T-Cell Micro-RNA Signature and Demonstration of the Major Role Played by miR-31, MiR-21 and Valproate in Foxp3 Expression Badran, Bassam - Universite Libre de Bruxells

199 Role of Heparan Sulfate Proteoglycans in HIV-1 Tat-Induced Transendothelial Migration of Lymphoid Cells Rusnati, Marco - University of Brescia

200 The β Chemokines MDC, TARC and I-309 are an Important Component of the Soluble Anti-X4 Activity Secreted by CD4+ and CD8+ T Cells Cocchi, Fiorenza - Institute of Human Virology

201 Adherence to Highly Active Antiretroviral Therapy Among HIV Infected Children in Kano, Nigeria Zubayr, B.M - Institute of Human Virology Nigeria

202 The MHC Class II Transactivator CIITA, a Restriction Factor for Human Retroviruses and a Molecule Making the Bridge Between Adaptive and Intrinsic Immunity Accolla, Roberto - University of Insubria

203 Donation or Infection: Retrospective Assessment of Transfusion Transmissible HIV Among Sickle Cell Anemia Patients Yahaya, A.H. - Institute of Human Virology Nigeria

204 Adolescents' Willingness to Participate in HIV Vaccine Clinical Trial Preparedness in Nigeria Otuonye, N.M. - Nigerian Institute of Medical Research

205 Challenges to Pediatric Adherence to ART Treatment and Strategies to Improve Adherence Among a Large Cohort of Uganda Children Marion, Natukunda - Mama's Club, Uganda

206 Predictors of Adherence for Patients on Highly Active Antiretroviral Therapy in HIV Treatment Program Adeyemi, Adedayo - Healthmatch International

207 Dysregulated Physiological and Emotional Responses to Stress are Associated with Cytokine and Chemokine HIV Progression Mediators and with CD4+ Count at 36-month Follow Up Temoshok, Lydia - Institute of Human Virology

208 Correlation Between Circulating HIV-1 RNA and HIV-1 DNA Copies and the Neutralizing Antibody Response Sajadi, Mohammad - Institute of Human Virology

209 Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance Fiorentini, Simona - University of Brescia

210 Low Post-Seroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV+ Fast Progressors Audige, Annette - University of Zurich

211 Virological Characterization of HIV-1 Acute Infection by Ultra-Sensitive Next Generation Sequencing Abbate, I. - National Institute for Infectious Diseases “L Spallanzani” 

212 Profiling Responses to a Lassa Vaccine Delivered to SIV-Infected Rhesus Macaques Salvato, Maria - Institute of Human Virology

213 A CD4-Independent gp41 Variant of HIV-1(BaL) Reitz, Marv - Institute of Human Virology

214 Derivation and Characterization of Novel Anti-HIV Envelope Monoclonal Antibodies from Macaques Vaccinated with a Constrained HIV Gp120 Immunogen and Challenged with SHIV162p3 Reid, William - Institute of Human Virology

215 In Vivo Binding and Retention of CD4-Specific DARPin in 57.2 in Macaques Pugach, Pavel - Center for Biomedical Research

216 Self-Renewing Monocytoid Cells (SRMC) Derived from Cultured Blood Monocytes as Targets and Hosts for Viruses Popovic, Mikulas - Institute of Human Virology

217 HIV Infection Risk Association with RCG Receptor Polymorphism Poonia, Bhawna - Institute of Human Virology

218 Characterization of Binding Affinity and Epitope Dynamics of Anti-HIV-1 Antibodies Mengistu, Meron - Institute of Human Virology

219 Characterization of Nurse Macrophage-Derived Cells That Express Stem Cell Markers Liu, Yiling - Institute of Human Virology

220 Novel Functional mAbs Against HIV-1 Gp120 from HIV Controller Guan, Yongjun - Institute of Human Virology

221 HIV Persistence in Dendritic Cells - Contribution of NK Cells and Pivotal Role of HMGB1 Gougeon, Marie-Lise - Institut Pasteur

222 HIV-1 p17 Activates PTEN and Inhibits Akt Signaling Pathway in B Cells: Evidence for a Variant with Different Effects on Signaling and Cell Growth Giagulli, Cinzia - University of Brescia

223 The Newly Discovered Human Endogenous Retrovirus HERV-K 111 is Transcriptionally Active Only Upon HIV Infection Contreras-Galindo, Rafael - University of Michigan

224 The MHC-II Transactivator, CIITA, Inhibits Tat-Mediated HIV-1 LTR Transactivation and Virus Replication in Human U937 Monocytic Cells Forlani, Greta - University of Insubria

225 Small Animal Model Systemic and Primary Central Nervous System AIDS/NHL Bryant, J.L. - Institute of Human Virology

226 Engineered Lactobacilli as a System to Screen Potent RANTES Mutants Acting as Live CR5 Antagonist-HIV-1 Blockers Vangelista, Luca - San Raffaele Scientific Institute

227 Kinome Profiling of Bovine Leukemia Virus-Induced Ovine Leukemia: An Approach for Identifying Altered Signaling Pathways and Drugable Targets in Cancer Van den Broeke, Anne - Universite Libre de Bruxelles

228 Glycosylation Profiling of the HIV-1 gp120 CD4 Full Length Single Chain Complex Wang, Lai-Xi - Institute of Human Virology

229 HIV-1 Replication Through hHR23A-Mediated Interaction of Vpr with 26S Proteasome Zhao, Richard - UMSOM - IHV

230 VEGFR2 and αVβ3 Recruitment and Cross-Talk at the Basal Aspect of HIV-1 Tat-Adherent Endothelial Cells Drives pp0src/ERL1/2 Activation, Cytoskeleton Organization and Pro-angiogenic Activation Urbinati, Chiara - University of Brescia

231 The MHC Class II Transactivator, CIITA, is a Viral Restriction Factor for Human Oncogenic Retroviruses Tosi, Giovanna - University of Insubria

232 Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of Chronically Infected, Treatment-Naïve HIV-1 Patients Romerio, Fabio - Institute of Human Virology

233 Interleukin-21 (IL-21) is a Determinant of H1N1 Vaccine Induced Antibody Response in HIV-Infected Persons Pahwa, Savita - Developmental Center for AIDS Research, Department of Microbiology and Immunology.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.